This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Ranked Momentum Stocks to Buy for June 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 3rd
Zacks.com featured highlights include: eXp World, Dropbox, Medifast and Logitech International
by Zacks Equity Research
Zacks.com featured highlights include: eXp World, Dropbox, Medifast and Logitech International
4 Promising Top-Ranked Liquid Stocks to Enrich Your Portfolio
by Zacks Equity Research
Here are four top-ranked liquid stocks, including Logitech (LOGI), that investors can bank on for alluring returns.
Top Ranked Income Stocks to Buy for June 1st
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, June 1st.
Are Investors Undervaluing Medifast (MED) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Medifast (MED) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Top Ranked Income Stocks to Buy for May 28th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 28th.
Consumer Confidence Rebounds in May: 5 Winners
by Ritujay Ghosh
A massive $3 trillion rescue fund, hopes of a COVID-19 vaccine and reopening of businesses are helping consumers regain their lost confidence.
Here's How Americans Are Regaining Confidence: 5 Picks
by Sanghamitra Saha
U.S. consumer confidence gained in May and beat the expectations of economists polled by Dow Jones.
Why Medifast (MED) Stock Might be a Great Pick
by Zacks Equity Research
Medifast (MED) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Zacks Analyst Blog Highlights: Equinox Gold, Medifast, NeoPhotonics, Veritiv and Tutor Perini
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Equinox Gold, Medifast, NeoPhotonics, Veritiv and Tutor Perini
Dig Into DuPont Technique to Grab 3 Quality Picks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
6 Stocks with Improving Prospects
by Sejuti Banerjea
These 6 stocks are good opportunities, no matter how you look at them.
Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast
by Zacks Equity Research
Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast
Medifast, Inc. (MED) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Medifast, Inc. (MED).
4 Top-Ranked Liquid Stocks to Bet on for Alluring Returns
by Zacks Equity Research
Here are four top-ranked liquid gems that investors can add to portfolio for remarkable returns.
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Are Investors Undervaluing Medifast (MED) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New Strong Buy Stocks for May 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Medifast (MED) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 46.21% and 10.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Income Stocks to Buy for April 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 20th.
Equities Partially Recover Lost Ground on $2 Trillion Relief Bill
by David Borun
Congress passes the biggest stimulus plan in history, providing support for a stock market that had been rocked by Covid-19 shutdowns.
The Extreme Risks of Trading Your Own Retirement Assets - March 02, 2020
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
New Strong Buy Stocks for March 2nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today: